Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as EGFR and BRAFV600E dual inhibitors with potent antiproliferative and antioxidant activities
Hesham A. M. Gomaa, Mohamed E. Shaker, Sami I. Alzarea, Omnia M. Hendawy, Fatma A. Mohamed, Ahmed M. Gouda, Asmaa T. Ali, Martha M. Morcoss, Mostafa Abdelrahman, Laurent Trembleau, Bahaa G. M. Youssif
Topics & Concepts
ChemistryEGFR inhibitorsIC50ErlotinibTroloxIndole testIn vitroAntioxidantPharmacologyCancer cellCombinatorial chemistryStereochemistryBiochemistryEpidermal growth factor receptorCancerReceptorAntioxidant capacityMedicineInternal medicineSynthesis and biological activityCancer therapeutics and mechanismsComputational Drug Discovery Methods